Anti-inflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

Anti-inflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

Background: Experimental studies revealed pro-inflammatory properties of angiotensin II. We evaluated antiinflammatory effects of the angiotensin II subtype 1 receptor antagonist olmesartan medoxomil alone and in cotherapy with the HMG-CoA reductase inhibitor pravastatin, in patients with essential...

Full description

Bibliographic Details
Main Authors:	Danilo Fliser, Konrad Buchholz, Hermann Haller
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	angiotensin atherosclerosis cholesterol hypertension inflammation
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2157

Similar Items

Large arteries and angiotensin II blockade in hypertension
by: Michel E. Safar
Published: (2010-09-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
by: C. Ferrario
Published: (2010-12-01)

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
by: R. D. Smith, et al.
Published: (2010-12-01)

Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system
by: J.S. Camelo Jr., et al.
Published: (2012-02-01)

Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system
by: J.S. Camelo Jr., et al.
Published: (2012-02-01)

COMPARATIVE EFFICACY OF BLOCKADE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM WITH COMBINATIONS OF ALISKIREN AND AMLODIPINE, RAMIPRIL AND AMLODIPINE IN PATIENTS WITH ESSENTIAL HYPERTENSION
by: E. Krutikov, et al.
Published: (2017-12-01)

Effect of myrtus communis extract on serum cytokines in angiotensin dependent hypertensive rats
by: Zatiye Ayca Cevikelli Yakut, et al.
Published: (2020-06-01)

Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension
by: Rafiye Ciftciler, et al.
Published: (2020-08-01)

Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
by: Gabriela M. Silva, et al.
Published: (2020-09-01)

Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system
by: S. G. Kanorskiy
Published: (2021-04-01)

Blockade of the Neprilysin and Angiotensin Ameliorates Oxidative Stress in the Cardiovascular Target Tissues of Dexamethasone-induced Hypertensive Rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-01-01)

The role of the angiotensins in the pathogenesis of inflammatory joint disease
by: Andrei V. Gordeev, et al.
Published: (2021-05-01)

Gut Microbiota Promote Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
by: Susanne H. Karbach, et al.
Published: (2016-09-01)

A Single Angiotensin II Hypertensive Stimulus Is Associated with Prolonged Neuronal and Immune System Activation in Wistar-Kyoto Rats
by: Jasenka Zubcevic, et al.
Published: (2017-08-01)

Management of hypertension: Insights into prescribing behavior with focus on angiotensin receptor blockers
by: S Ramakrishnan, et al.
Published: (2017-01-01)

Hypertension and angiotensin system inhibitors in patients with metastatic renal cell carcinoma
by: Lisa Derosa, et al.
Published: (2016-11-01)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
by: Si-Hyuck Kang, et al.
Published: (2021-06-01)

Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized controlled trial
by: Elizabeth do Espirito Santo Cestário, et al.
Published: (2018-02-01)

Relationship between the expression of angiotensin II receptors type 1 and vasoactive regulators in arterial hypertension
by: Anna V. Logatkina, et al.
Published: (2020-11-01)

Antihypertensive effects of angiotensin-(1-7)
by: M.C. Chappell, et al.
Published: (1998-09-01)

Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension
by: Qian Xu, et al.
Published: (2021-09-01)

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats
by: Shao-Jung Hsu, et al.
Published: (2020-04-01)

Effect of Ramipril on Renin-Angiotensin-Aldosterone System of Young and Middle-Aged Patients with Hypertension
by: Hui-Ling Yuan
Published: (2020-12-01)

Krüppel-Like Factor 15 Modulates CXCL1/CXCR2 Signaling-Mediated Inflammatory Response Contributing to Angiotensin II-Induced Cardiac Remodeling
by: Shun He, et al.
Published: (2021-04-01)

Angiotensin II Induces C-Reactive Protein Expression via AT1-ROS-MAPK-NF-κB Signal Pathway in Hepatocytes
by: Jingjing Zhao, et al.
Published: (2013-09-01)

Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension
by: A A Khadartsev, et al.
Published: (2017-12-01)

Tissue synthesis of some components of the renin-angiotensin system in hypertensive patients with localized kidney cancer
by: R. A. Osokin, et al.
Published: (2020-04-01)

ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01)

Reciprocal Roles of Angiotensin II and Angiotensin II Receptors Blockade (ARB) in Regulating Cbfa1/RANKL via cAMP Signaling Pathway: Possible Mechanism for Hypertension-Related Osteoporosis and Antagonistic Effect of ARB on Hypertension-Related Osteoporosis
by: Ji-Yao Li, et al.
Published: (2011-06-01)

Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology
by: Amanda St. Paul, et al.
Published: (2020-06-01)

Interlinking Antecedent Malaria and Hypertension Through Angiotensin II in India
by: Aparna Tiwari, et al.
Published: (2021-10-01)

Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and Induction of Oxidative Stress
by: Dinesh Aryal, et al.
Published: (2021-12-01)

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients*
by: LeAnne T. Bloedon, et al.
Published: (2008-06-01)

The Effects of Hydroalchoholic Extract of Teucrium polium L. on Hypertension Induced by Angiotensin II in Rats
by: Maryam Mahmoudabady, et al.
Published: (2014-01-01)

The Role of P2X7 Purinergic Receptors in the Renal Inflammation Associated with Angiotensin II-induced Hypertension
by: Rocio Bautista-Pérez, et al.
Published: (2020-06-01)

Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice
by: M. Florencia Iulita, et al.
Published: (2018-02-01)

Acute AT1 receptor blockade does not improve the depressed baroreflex in rats with chronic renal hypertension
by: V.M.A. Farah, et al.
Published: (2000-12-01)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
by: Zhang C, et al.
Published: (2021-02-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Die Bedeutung von Angiotensin II und "Peroxisome Proliferator-Activated Receptors" in vaskulären Zellen bei der Entstehung der Atheroskleose
by: Kintscher, Ulrich
Published: (2004)